Options volumes leaned bullish in both the SPDR Gold ETF (GLD) and VanEck Gold Miners ETF (GDX) on Tuesday.
JPMorgan says it’s time to buy these unloved safe stocks that pay dividends
The bank sees an attractive entry point for low-volatility stocks. These are the companies JPMorgan rates overweight.
Markets suggest stocks are on solid ground and crude oil could be in for a decline, Todd Gordon says
The VIX is saying that equities are in good shape and, if a resolution of the war is near, crude oil may plummet into the $80s, and maybe $70s, per barrel.
Jay Woods is watching two beaten-down software stocks into earnings this week
Jay Woods reviews two key software stocks reporting earnings this week, as well as what a new inflation report could mean for new Fed chair Kevin Warsh.
Ferrari shares slump 6% after new electric vehicle is bashed online. Why Wall Street says buy the dip
The Italian luxury car maker unveiled its first all-electric vehicle called Luce. Online critics were unimpressed.
Cybersecurity stocks are surging. One looks promising into earnings
Mike Khouw is long Zscaler into earnings after the close.
Chip stocks continue to surge. Here’s how to buy into the trend for less
Mike Khouw happens to like one surging chip stock in particular: Marvell Technology.
The Avis ‘circus’ messed with the transports sector this year. Josh Brown finds the real Best Stocks in the space
Josh Brown and Sean Russo take a look at some of the transportation names in their Best Stocks list.
A defense stock down big lately is primed for a turnaround. How to play a comeback with less risk
Northrop Grumman has suffered an eye-popping 30% collapse in under two months.
Goldman says this biotech stock will be a winner thanks to a one-of-a-king treatment
Hemab Therapeutics is likely to gain ground as its treatment for a pair of rare bleeding disorders shows signs of efficacy, per Goldman Sachs.